{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:58:56Z","timestamp":1770505136045,"version":"3.49.0"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2011,7,15]],"date-time":"2011-07-15T00:00:00Z","timestamp":1310688000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0021823","type":"journal-article","created":{"date-parts":[[2011,7,15]],"date-time":"2011-07-15T20:52:23Z","timestamp":1310763143000},"page":"e21823","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":63,"title":["A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced Disease"],"prefix":"10.1371","volume":"6","author":[{"given":"Dennis M.","family":"Lindell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan B.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria P.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara E.","family":"Kallal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip K.","family":"Lundy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Hamouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas W.","family":"Lukacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,7,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/01.inf.0000053887.26571.eb","article-title":"Links between respiratory syncytial virus bronchiolitis and childhood asthma: clinical and research approaches.","volume":"22","author":"PJ Openshaw","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1067\/S0022-3476(03)00508-0","article-title":"Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection.","volume":"143","author":"RC Welliver","year":"2003","journal-title":"J Pediatr"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/01.inf.0000053880.92496.db","article-title":"Respiratory syncytial virus and other respiratory viruses.","volume":"22","author":"RC Welliver","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/01.inf.0000053882.70365.c9","article-title":"Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus.","volume":"22","author":"LG Stensballe","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"ref5","first-page":"209","article-title":"Systematic review of the biology and medical management of respiratory syncytial virus infection.","volume":"48","author":"CP Black","year":"2003","journal-title":"Respir Care"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.","volume":"375","author":"H Nair","year":"2010","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/eji.1830260915","article-title":"In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to freund's complete adjuvant, but continues to induce T helper 2 cytokine production.","volume":"26","author":"JM Brewer","year":"1996","journal-title":"Eur J Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.4049\/jimmunol.163.12.6448","article-title":"Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling.","volume":"163","author":"JM Brewer","year":"1999","journal-title":"J Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends.","volume":"82","author":"N Petrovsky","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1084\/jem.20071087","article-title":"Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells.","volume":"205","author":"M Kool","year":"2008","journal-title":"J Exp Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e2954","DOI":"10.1371\/journal.pone.0002954","article-title":"Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine.","volume":"3","author":"PE Makidon","year":"2008","journal-title":"PLoS ONE"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1128\/IAI.00070-07","article-title":"Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.","volume":"75","author":"AU Bielinska","year":"2007","journal-title":"Infect Immun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/CVI.00440-07","article-title":"A novel, killed-virus nasal vaccinia virus vaccine.","volume":"15","author":"AU Bielinska","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/aid.2007.0148","article-title":"Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates.","volume":"24","author":"AU Bielinska","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1016\/S0264-410X(03)00381-5","article-title":"Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion.","volume":"21","author":"A Myc","year":"2003","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0001-706X(03)00120-7","article-title":"Inactivation of Ebola virus with a surfactant nanoemulsion.","volume":"87","author":"AA Chepurnov","year":"2003","journal-title":"Acta Trop"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1086\/315124","article-title":"A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species.","volume":"180","author":"T Hamouda","year":"1999","journal-title":"J Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1078\/0944-5013-00069","article-title":"A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi.","volume":"156","author":"T Hamouda","year":"2001","journal-title":"Microbiol Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/AAC.00691-08","article-title":"In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species.","volume":"53","author":"JJ LiPuma","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/A:1021129710316","article-title":"The fungicidal activity of novel nanoemulsion (X8W60PC) against clinically important yeast and filamentous fungi.","volume":"155","author":"A Myc","year":"2002","journal-title":"Mycopathologia"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/eji.200838155","article-title":"CXCL10\/CXCR3-mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8(+) T cell efficacy.","volume":"38","author":"DM Lindell","year":"2008","journal-title":"Eur J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0264-410X(00)00213-9","article-title":"Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice.","volume":"19","author":"A Boelen","year":"2000","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1086\/516152","article-title":"Animal models of respiratory syncytial virus infection.","volume":"25","author":"LG Byrd","year":"1997","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1164\/ajrccm\/152.4_Pt_2.S63","article-title":"Pathogenesis of respiratory syncytial virus vaccine-augmented pathology.","volume":"152","author":"BS Graham","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12026-007-0071-6","article-title":"Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.","volume":"39","author":"EM Castilow","year":"2007","journal-title":"Immunol Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1513\/pats.200502-014AW","article-title":"Cytokines and respiratory syncytial virus infection.","volume":"2","author":"RA Tripp","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/01902140701756604","article-title":"Interleukin-17 in pulmonary host defense.","volume":"33","author":"SJ Aujla","year":"2007","journal-title":"Exp Lung Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","article-title":"Interleukin-17 family members and inflammation.","volume":"21","author":"JK Kolls","year":"2004","journal-title":"Immunity"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaut.2008.04.017","article-title":"Role of Th1 and Th17 cells in organ-specific autoimmunity.","volume":"31","author":"V Dardalhon","year":"2008","journal-title":"J Autoimmun"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells.","volume":"27","author":"T Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"L505","DOI":"10.1152\/ajplung.00066.2007","article-title":"Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection.","volume":"293","author":"S Wiehler","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.4049\/jimmunol.1000818","article-title":"Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype.","volume":"185","author":"N Yeh","year":"2010","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.4049\/jimmunol.0900657","article-title":"IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge.","volume":"182","author":"KK McKinstry","year":"2009","journal-title":"J Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.4049\/jimmunol.0801814","article-title":"Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge.","volume":"182","author":"H Hamada","year":"2009","journal-title":"J Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.4049\/jimmunol.179.6.3917","article-title":"IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17.","volume":"179","author":"S Kohyama","year":"2007","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.4049\/jimmunol.0803868","article-title":"A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production.","volume":"182","author":"DC Newcomb","year":"2009","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.0900237","article-title":"Cutting edge: Lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels.","volume":"182","author":"Z Jaffar","year":"2009","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000226256","article-title":"Defensins in viral infections.","volume":"1","author":"J Ding","year":"2009","journal-title":"J Innate Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/PL00000914","article-title":"The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity.","volume":"58","author":"D Yang","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.4049\/jimmunol.1000733","article-title":"Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation.","volume":"185","author":"NW Lukacs","year":"2010","journal-title":"J Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.imbio.2008.07.022","article-title":"Interferon-alpha controls IL-17 expression in vitro and in vivo.","volume":"213","author":"AR Moschen","year":"2008","journal-title":"Immunobiology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4049\/jimmunol.139.1.10","article-title":"B cell stimulatory factor-1 (interleukin 4) prepares resting murine B cells to secrete IgG1 upon subsequent stimulation with bacterial lipopolysaccharide.","volume":"139","author":"CM Snapper","year":"1987","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.3107127","article-title":"Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.","volume":"236","author":"CM Snapper","year":"1987","journal-title":"Science"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1084\/jem.167.1.183","article-title":"Differential regulation of IgG1 and IgE synthesis by interleukin 4.","volume":"167","author":"CM Snapper","year":"1988","journal-title":"J Exp Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1073\/pnas.1009234107","article-title":"Proinflammatory T helper type 17 cells are effective B-cell helpers.","volume":"107","author":"M Mitsdoerffer","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nm.1894","article-title":"Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease.","volume":"15","author":"MF Delgado","year":"2009","journal-title":"Nat Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1016\/j.vaccine.2010.06.041","article-title":"Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation.","volume":"28","author":"T Stegmann","year":"2010","journal-title":"Vaccine"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1099\/vir.0.011684-0","article-title":"Formulation of bovine respiratory syncytial virus fusion protein with CpG oligodeoxynucleotide, cationic host defence peptide and polyphosphazene enhances humoral and cellular responses and induces a protective type 1 immune response in mice.","volume":"90","author":"J Kovacs-Nolan","year":"2009","journal-title":"J Gen Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0264-410X(01)00287-0","article-title":"Respiratory syncytial virus vaccine development.","volume":"20","author":"JE Crowe Jr","year":"2001","journal-title":"Vaccine"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1097\/01.inf.0000108194.71892.95","article-title":"The future of respiratory syncytial virus vaccine development.","volume":"23","author":"FP Polack","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2217\/17460794.3.5.445","article-title":"Overcoming T cell-mediated immunopathology to achieve safe RSV vaccination.","volume":"3","author":"EM Castilow","year":"2008","journal-title":"Future Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cimid.2007.07.008","article-title":"Human and bovine respiratory syncytial virus vaccine research and development.","volume":"31","author":"G Meyer","year":"2008","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0264-410X(98)00155-8","article-title":"Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine.","volume":"17","author":"ML Herlocher","year":"1999","journal-title":"Vaccine"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2353\/ajpath.2006.051055","article-title":"Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus.","volume":"169","author":"NW Lukacs","year":"2006","journal-title":"Am J Pathol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/JCM.26.8.1595-1597.1988","article-title":"Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity.","volume":"26","author":"BR Murphy","year":"1988","journal-title":"J Clin Microbiol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.4049\/jimmunol.151.4.2032","article-title":"Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus.","volume":"151","author":"BS Graham","year":"1993","journal-title":"J Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.2353\/ajpath.2007.070578","article-title":"Respiratory virus-induced regulation of asthma-like responses in mice depends upon CD8 T cells and interferon-gamma production.","volume":"171","author":"JJ Smit","year":"2007","journal-title":"Am J Pathol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/eji.200425439","article-title":"Respiratory syncytial virus-induced exaggeration of allergic airway disease is dependent upon CCR1-associated immune responses.","volume":"35","author":"AE John","year":"2005","journal-title":"Eur J Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0002-9440(10)62258-4","article-title":"Temporal Production of CCL28 Corresponds to Eosinophil Accumulation and Airway Hyperreactivity in Allergic Airway Inflammation.","volume":"166","author":"AE John","year":"2005","journal-title":"Am J Pathol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2353\/ajpath.2008.070537","article-title":"A key role for CC chemokine receptor 1 in T-cell-mediated respiratory inflammation.","volume":"172","author":"MA Schaller","year":"2008","journal-title":"Am J Pathol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.4049\/jimmunol.174.4.2054","article-title":"Attenuation of allergen-induced responses in CCR6\u2212\/\u2212 mice is dependent upon altered pulmonary T lymphocyte activation.","volume":"174","author":"SK Lundy","year":"2005","journal-title":"J Immunol"},{"key":"ref62","article-title":"CD8(+) T cell contributions to allergen induced pulmonary inflammation and airway hyperreactivity.","author":"MA Schaller","year":"2005","journal-title":"Eur J Immunol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/labinvest.3700419","article-title":"Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen-induced asthma.","volume":"86","author":"AA Berlin","year":"2006","journal-title":"Lab Invest"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"e3129","DOI":"10.1371\/journal.pone.0003129","article-title":"B cell antigen presentation promotes Th2 responses and immunopathology during chronic allergic lung disease.","volume":"3","author":"DM Lindell","year":"2008","journal-title":"PLoS One"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/382958","article-title":"Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo.","volume":"189","author":"AL Miller","year":"2004","journal-title":"J Infect Dis"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/JCM.43.5.2356-2362.2005","article-title":"Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus.","volume":"43","author":"SM Perkins","year":"2005","journal-title":"J Clin Microbiol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1128\/JVI.01853-08","article-title":"A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction.","volume":"83","author":"ML Moore","year":"2009","journal-title":"J Virol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays.","volume":"221","author":"A Frey","year":"1998","journal-title":"J Immunol Methods"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0021823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T04:33:35Z","timestamp":1686198815000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0021823"}},"subtitle":[],"editor":[{"given":"Malcolm Gracie","family":"Semple","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,7,15]]},"references-count":68,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2011,7,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0021823","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,15]]}}}